Overview


According to FutureWise analysis the market for Oncology Nutrition in 2023 is US$ 2.21 billion, and is expected to reach US$ 4.38 billion by 2031 at a CAGR of 8.90%.

The medical specialty of oncology focuses on detecting, preventing, and treating cancer. Oncology nutrition refers to food and nutrition for a cancer patient during or after treatment. One of the main factors of illness and mortality worldwide is malignant diseases. Along with population aging, it is anticipated that both the incidence and prevalence of cancer cases will rise in the ensuing decades. Significant advancements in cancer treatment (surgery, systemic therapy, radiotherapy) have been made thanks to multimodal therapies, leading to increased cure rates and prolonged survival in the palliative context. Based on the aforementioned data, it is projected that the number of patients in healthcare systems worldwide—particularly older people—will significantly expand. Regardless of whether the patient is receiving curative or palliative care, the effectiveness and tolerance of a multimodal treatment approach depend on several variables, with nutrition ranking as one of the most crucial.

The primary factor contributing to the expansion of the market's growth is the rise in the prevalence of cancer. The rising cost of healthcare is a significant issue affecting the market for oncology nutrition. The oncology nutrition industry will grow due to the development of basic techniques, more government financing, and expanding public and private activities to raise awareness about the nutrition of cancer patients. The need for healthy food from the homecare industry is expected to rise, and changing lifestyles will also benefit the market's growth rate.

FutureWise Market Research has published a report that provides an insightful analysis of oncology nutrition market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, the oncology nutrition market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Danone S.A.
  • Pfizer Inc.
  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Grifols S.A.
  • Baxter International, Inc.
  • Nestlé S.A.
  • Abbott Laboratories
  • Sichuan Kelun Pharmaceutical Co., Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Oncology Nutrition Market:

  • In July 2022- After a five-year licensing process from the Chinese government, Foods for Special Medical Purpose (FSMP) in China was first introduced by Nestle for patients with tumor-related diseases.

Patients with cancer or those receiving cancer treatment need enough nutrition to decrease side effects. This can be achieved with the help of an oncology dietitian and a well-planned diet. One of the major problems cancer patients are treated for is managing or preventing malnutrition. Anorexia (lack of appetite or desire to eat) and cachexia (weakness, weight loss, and loss of fat and muscle) are the main causes of malnutrition. Malnutrition affects about 70% of cancer patients, mostly caused by poor food consumption, insufficient physical exercise, cancer symptoms, and cancer drugs. To give patients the nutrients they require before and after treatment to prevent malnutrition, oncology nutrition is in great demand. Moreover, oncology nutrition is expected to see significant development in demand due to the implementation of nutritional review programs, notably during cancer cachexia and pre-cachexia. Tools for gathering information on the nutritional state of different patients have progressed quickly over the last decade. These developments have led to personalized oncology nutrition therapy as a desirable treatment option for cancer patients prone to malnutrition. Individualized oncology nutritional advice is becoming increasingly common because oncology nutrition therapy varies from patient to patient. A growing number of cancer patients are using oncology nutrition to prevent nutritional deterioration. The market for oncology nutrition is expected to increase rapidly due to the growing demand for personalized nutrition to enhance cancer patients' quality of life. However, the requirement to follow stringent regulations for developing and introducing oncology nutritional products, drawn-out clinical trials, the potential for regulatory bodies to reject a product, and limited or nonexistent reimbursements in various countries are expected to hinder the market's potential for revenue growth.

By Nutrition

  • Enteral Nutrition
  • Parenteral Nutrition

By Formula

  • Standard Formula
  • Elemental Formula
  • Specialized Formula

By Cancer

  • Head and Neck Cancers
  • Colorectal Cancer
  • Hematology Cancer
  • Prostate Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Lung Cancer
  • Pancreatic Cancer
  • Other Cancers  

By Distribution Channel

  • Inpatient Nutrition
  • Outpatient Nutrition

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The increased incidence of cancer and the accessibility of cutting-edge healthcare infrastructure, among other important variables, are accounted for the region's growth. For example, according to the American Cancer Society's projection for 2022, 1.9 million new instances of cancer are anticipated to be diagnosed in the United States. Additionally, the market for cancer nutrition supplements is growing due to government initiatives, product introductions, and partnerships. To inform cancer patients and healthcare professionals about the significance of oncology nutrition, numerous certification programs and awareness seminars are held locally, further propelling the region's market growth.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Oncology Nutrition Market By Nutrition, By Formula, By Cancer, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- Product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Oncology Nutrition Market Variables, Trends and Scope
    •     1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Oncology Nutrition Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Oncology Nutrition Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Oncology Nutrition Market, By Nutrition Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Enteral Nutrition
        2. Parenteral Nutrition

  • 8.   Oncology Nutrition Market, By Formula Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Standard Formula
        2. Elemental Formula
        3. Specialized Formula

  • 9.   Oncology Nutrition Market, By Cancer Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Head and Neck Cancers
        2. Colorectal Cancer
        3. Hematology Cancer
        4. Prostate Cancer
        5. Breast Cancer
        6. Gastrointestinal Cancer
        7. Lung Cancer
        8. Pancreatic Cancer
        9. Other Cancers

  • 10.   Oncology Nutrition Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Inpatient Nutrition
        2. Outpatient Nutrition

  • 11.   North America Oncology Nutrition Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Oncology Nutrition Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Oncology Nutrition Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Oncology Nutrition Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Oncology Nutrition Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Danone S.A.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Pfizer Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. B. Braun Melsungen AG
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Fresenius Kabi AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Grifols S.A.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Baxter International, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Nestlé S.A.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Abbott Laboratories
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Sichuan Kelun Pharmaceutical Co., Ltd.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients